Swiss regenerative therapy company sets its sights on the Middle East

With substantial regional investment and local partnerships, the forthcoming opening of Lab Dom's Dubai headquarters marks the beginning of the company's strategy to shift operations and manufacturing to the UAE.

Founded in 1991 by entrepreneurial husband and wife team, Mike Chan and Michelle Wong, Lab Dom is a world-leader in cellular technology and pharmaceuticals, providing rejuvenation and revitalisation therapies to combat aging.

Lab Dom's medical research team, based in state-of-the-art laboratories in Carouge in Switzerland, is committed to innovative research and development in the rapidly expanding fields of regenerative medicine and anti-aging cellular therapy fields.

Leveraging advances in biomedical cellular technology, Lab Dom's scientists have invented several world-renowned bio-regenerative medicine brands, including the revolutionary MFIII of Switzerland, a natural rejuvenation method originating from Switzerland that has proven effectiveness against aging and chronic diseases.

Explaining Lab Dom's foray into the Middle East, Michael Lodge, Lab Dom's Chief Executive Officer, says: "Cellular rejuvenation has revolutionized the anti-ageing industry and Lab Dom's range of groundbreaking products is leading the way in providing lasting rejuvenative solutions. The decision to launch a regional office in Dubai is part of our strategy to extend Lab Dom's global reach, as well as providing access to an increasingly influential market. The discerning Middle Eastern consumer is astute to the new technologies arriving in the market and is driven to look and feel their best, and Lab Dom's innovative range of products will empower them to achieve this.

Lab Dom's commitment to making Dubai the heart of its regional presence has been facilitated by the Habtoor family, who are great believers in the pioneering products and will be an integral part of the regional expansion and business development.